Deals · scored for Aarav — Bengaluru family office
Showing 1–27 of 27 · every row links to its sources
Sample size: n = 27Showing 1–27 of 27. Every row links to its sources.
65Relevance 65/100 for this profile. High: scores 60–79. A strong fit with this mandate. Open the row for the breakdown.
Formial Labs🟠 HighHigh: scores 60–79. A strong fit with this mandate.$303K· Pre-seed· Healthtech· Bengaluru· 15 OctPre-seed, in mandate · Bengaluru, primary geography
✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.GNews: startup raises crore ↗+1
✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.
Formial Labs is a doctor-led personalised prescription skincare startup.
Raw 65.2 × confidence 1Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 65.2
48Relevance 48/100 for this profile. Relevant: scores 40–59. A partial fit; worth a skim. Open the row for the breakdown.Vitonnix🟡 RelevantRelevant: scores 40–59. A partial fit; worth a skim.undisclosed· Seed· Healthtech· 15 OctSeed, in mandate · Healthtech → preventive healthcare relates closely to care deliverysingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.VCCircle ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.
Sector fitHealthtech → preventive healthcare relates closely to care delivery24/30
77Relevance 77/100 for this profile. High: scores 60–79. A strong fit with this mandate. Open the row for the breakdown.Confido Health🟠 HighHigh: scores 60–79. A strong fit with this mandate.$12.5M· Series A· Healthtech· 14 OctSeries A, in mandate · $13M, within $500K–$20Mdisputed: amountSources disagree on: amountEconomic Times Tech — Startups ↗+3
disputed: amountSources disagree on: amount
Confido Health develops artificial intelligence (AI) agents that automate administrative tasks for healthcare providers.
55Relevance 55/100 for this profile. Relevant: scores 40–59. A partial fit; worth a skim. Open the row for the breakdown.MakeO🟡 RelevantRelevant: scores 40–59. A partial fit; worth a skim.$9.4M· Undisclosed· Healthtech· Mumbai· 13 Oct$9.4M, within $500K–$20M · Mumbai, primary geography✓ 4 sourcesVerified: 4 independent publications reported this round and agree on the key facts.Inc42 ↗+3
✓ 4 sourcesVerified: 4 independent publications reported this round and agree on the key facts.
MakeO provides dental, skin, and hair treatments through a single platform, operating clear aligner brand Toothsi and clinical centres.
26Relevance 26/100 for this profile. Context: scores 20–39. Market background, not a mandate fit. Open the row for the breakdown.Nutriventia⚪ ContextContext: scores 20–39. Market background, not a mandate fit.undisclosed· Growth· Healthtech· 11 OctHealthtech → pharma supply (adjacent match) · Amount undisclosed (neutral, not penalised)single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.VCCircle ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.
Nutriventia develops and supplies branded nutraceutical ingredients and delivery platforms to formulators and wellness brands globally.
85Relevance 85/100 for this profile. Act now: scores 80+ (or forced up by a watchlist or adjacency override). Worth a look this week. Open the row for the breakdown.Sunfox Technologies🔴 Act nowAct now: scores 80+ (or forced up by a watchlist or adjacency override). Worth a look this week.$7.0M· Series A· Healthtech· Dehradun· 7 OctSupplier to Even Healthcare (tracked company) · Healthtech → care delivery (primary match) · Series A, in mandatesingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.Entrackr ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.
Sunfox Technologies develops portable and AI-enabled healthcare solutions, including a medical-grade ECG platform for cardiac care.
Sector fitHealthtech → care delivery (primary match)30/30
70Relevance 70/100 for this profile. High: scores 60–79. A strong fit with this mandate. Open the row for the breakdown.Kinetic Age🟠 HighHigh: scores 60–79. A strong fit with this mandate.$250K· Undisclosed· Healthtech· Bengaluru· 6 OctCompetes with Even Healthcare (tracked company) · Healthtech → care delivery (primary match) · Bengaluru, primary geographysingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.Entrackr ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.
Kinetic Age provides coordinated and personalised healthcare services under a single subscription for adults aged 40 and above.
Sector fitHealthtech → care delivery (primary match)30/30
Stage fit
56Relevance 56/100 for this profile. Relevant: scores 40–59. A partial fit; worth a skim. Open the row for the breakdown.CureMeAbroad🟡 RelevantRelevant: scores 40–59. A partial fit; worth a skim.$1.1M· Pre-seed· Healthtech· Pune· 6 OctPre-seed, in mandate · $1.1M, within $500K–$20Msingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.Entrackr ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.
CureMeAbroad operates a healthcare platform that helps international patients discover, verify, and book treatments at accredited hospitals abroad.
Sector fitHealthtech → care delivery adjacent24/30
Stage fit
65Relevance 65/100 for this profile. High: scores 60–79. A strong fit with this mandate. Open the row for the breakdown.Aignosis🟠 HighHigh: scores 60–79. A strong fit with this mandate.$416K· Seed· Healthtech· 1 OctSupplier to Even Healthcare (tracked company) · Healthtech → Diagnostics is listed core sub-sector · Seed, in mandatesingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Aignosis is a health tech company focused on diagnostics.
100Relevance 100/100 for this profile. Act now: scores 80+ (or forced up by a watchlist or adjacency override). Worth a look this week. Open the row for the breakdown.Vytalyou🔴 Act nowAct now: scores 80+ (or forced up by a watchlist or adjacency override). Worth a look this week.$936K· Pre-Series A· Healthtech· 30 SeptCompetes with Even Healthcare (tracked company) · Healthtech → In-Clinic Healthcare matches care delivery · Pre-Series A, in mandate✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗+1
✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
55Relevance 55/100 for this profile. Relevant: scores 40–59. A partial fit; worth a skim. Open the row for the breakdown.Primerry🟡 RelevantRelevant: scores 40–59. A partial fit; worth a skim.$738K· Pre-seed· Healthtech· 28 SeptPre-seed, in mandate · $738K, within $500K–$20Msingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
56Relevance 56/100 for this profile. Relevant: scores 40–59. A partial fit; worth a skim. Open the row for the breakdown.Disha🟡 RelevantRelevant: scores 40–59. A partial fit; worth a skim.$4.6M· Series A· Healthtech· 26 SeptSeries A, in mandate · $4.6M, within $500K–$20Msingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Entrackr ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Sector fitHealthtech → AI-powered health coaching (closely related to care delivery)
73Relevance 73/100 for this profile. High: scores 60–79. A strong fit with this mandate. Open the row for the breakdown.MyRx🟠 HighHigh: scores 60–79. A strong fit with this mandate.undisclosed· Seed· Healthtech· 24 SeptSupplier to Even Healthcare (tracked company) · Healthtech → Telemedicine matches care delivery · Seed, in mandate✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗+1
✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
MyRx is a primary healthcare infrastructure company.
30Relevance 30/100 for this profile. Context: scores 20–39. Market background, not a mandate fit. Open the row for the breakdown.Physioplus Healthcare⚪ ContextContext: scores 20–39. Market background, not a mandate fit.undisclosed· Undisclosed· Healthtech· 19 SeptHealthtech → digital physiotherapy platform (care delivery primary match) · Amount undisclosed (neutral, not penalised)single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Entrackr ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Physioplus Healthcare is a digital physiotherapy platform.
Sector fitHealthtech → digital physiotherapy platform (care delivery primary match)
100Relevance 100/100 for this profile. Act now: scores 80+ (or forced up by a watchlist or adjacency override). Worth a look this week. Open the row for the breakdown.TRUE ARTIS🔴 Act nowAct now: scores 80+ (or forced up by a watchlist or adjacency override). Worth a look this week.$1.2M· Seed· Healthtech· 16 SeptCompetes with Even Healthcare (tracked company) · Healthtech → In-Clinic Healthcare matches care delivery · Seed, in mandate✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗+1
✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
TRUE ARTIS provides in-clinic healthcare services.
46Relevance 46/100 for this profile. Relevant: scores 40–59. A partial fit; worth a skim. Open the row for the breakdown.Medulance🟡 RelevantRelevant: scores 40–59. A partial fit; worth a skim.$2.5M· Series A· Healthtech· 4 SeptSeries A, in mandate · $2.5M, within $500K–$20Msingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Medulance is a health tech company operating under B2B2C and B2G models.
Sector fitHealthtech → missing sub-sector evaluated on core sector
79Relevance 79/100 for this profile. High: scores 60–79. A strong fit with this mandate. Open the row for the breakdown.Ultrahuman🟠 HighHigh: scores 60–79. A strong fit with this mandate.$70.0M· Growth· Healthtech· 3 SeptUltrahuman is on the watchlist · 70th pct cheque for Growth (all sectors) (n=5); investor tier 100th pct (Nexus Venture Partners); 2 sources · Healthtech → Fitness & Wellness is unlisted sub-sector✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗+1
✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Ultrahuman operates in the health tech and fitness & wellness space under a B2C business model.
49Relevance 49/100 for this profile. Relevant: scores 40–59. A partial fit; worth a skim. Open the row for the breakdown.DocPharma🟡 RelevantRelevant: scores 40–59. A partial fit; worth a skim.$2.0M· Pre-Series A· Healthtech· 2 SeptPre-Series A, in mandate · $2.0M, within $500K–$20Msingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
DocPharma is a health tech startup operating on a B2B business model.
Sector fitHealthtech → missing sub-sector evaluated on core sector
24Relevance 24/100 for this profile. Context: scores 20–39. Market background, not a mandate fit. Open the row for the breakdown.xStep⚪ ContextContext: scores 20–39. Market background, not a mandate fit.undisclosed· Undisclosed· Healthtech· 1 SeptHealthtech → missing sub-sector evaluated on core sector · Amount undisclosed (neutral, not penalised)single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Sector fitHealthtech → missing sub-sector evaluated on core sector
80Relevance 80/100 for this profile. High: scores 60–79. A strong fit with this mandate. Open the row for the breakdown.Butterfly Learnings🟠 HighHigh: scores 60–79. A strong fit with this mandate.$6.7M· Pre-Series A· Healthtech· Mumbai· 19 AugHealthtech → Therapy (mental health primary match) · Pre-Series A, in mandatedisputed: stageSources disagree on: stagebackfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗+1
disputed: stageSources disagree on: stagebackfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Butterfly Learnings is a health tech company offering therapy services.
70Relevance 70/100 for this profile. High: scores 60–79. A strong fit with this mandate. Open the row for the breakdown.LISSUN🟠 HighHigh: scores 60–79. A strong fit with this mandate.$5.0M· Series A· Healthtech· 18 AugHealthtech → Therapy (mental health primary match) · Series A, in mandate✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗+1
✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
69Relevance 69/100 for this profile. High: scores 60–79. A strong fit with this mandate. Open the row for the breakdown.Ayati Devices🟠 HighHigh: scores 60–79. A strong fit with this mandate.$1.6M· Pre-Series A· Healthtech· Bengaluru· 11 AugPre-Series A, in mandate · $1.6M, within $500K–$20M✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗+1
✓ 2 sourcesVerified: 2 independent publications reported this round and agree on the key facts.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Health tech company developing healthcare devices.
21Relevance 21/100 for this profile. Context: scores 20–39. Market background, not a mandate fit. Open the row for the breakdown.UN:BLOC⚪ ContextContext: scores 20–39. Market background, not a mandate fit.undisclosed· Undisclosed· Healthtech· 3 AugHealthtech → missing sub-sector evaluated on core sector · Amount undisclosed (neutral, not penalised)single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Sector fitHealthtech → missing sub-sector evaluated on core sector
51Relevance 51/100 for this profile. Relevant: scores 40–59. A partial fit; worth a skim. Open the row for the breakdown.CAROL.ai🟡 RelevantRelevant: scores 40–59. A partial fit; worth a skim.$10.0M· Series A· Healthtech· 25 JulSeries A, in mandate · $10M, within $500K–$20Msingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Entrackr ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Sector fitHealthtech → missing sub-sector evaluated on core sector
45Relevance 45/100 for this profile. Relevant: scores 40–59. A partial fit; worth a skim. Open the row for the breakdown.Bioscan Research🟡 RelevantRelevant: scores 40–59. A partial fit; worth a skim.$1.0M· Seed· Healthtech· 22 JulSeed, in mandate · $1.0M, within $500K–$20Msingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Bioscan Research develops medical equipment in the health tech sector.
Sector fitHealthtech → Medical Equipments (unmentioned sub-sector in core)
53Relevance 53/100 for this profile. Relevant: scores 40–59. A partial fit; worth a skim. Open the row for the breakdown.Mandrake Bio🟡 RelevantRelevant: scores 40–59. A partial fit; worth a skim.$1.7M· Pre-seed· Healthtech· 16 JulPre-seed, in mandate · $1.7M, within $500K–$20Msingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Inc42 ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Mandrake Bio is a B2B lifescience startup in health tech.
49Relevance 49/100 for this profile. Relevant: scores 40–59. A partial fit; worth a skim. Open the row for the breakdown.Circle Health🟡 RelevantRelevant: scores 40–59. A partial fit; worth a skim.$6.0M· Series A· Healthtech· 11 JulSeries A, in mandate · $6.0M, within $500K–$20Msingle sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.Entrackr ↗
single sourceOnly one publication has reported this round so far. Treat the numbers as provisional until a second source confirms.backfillBackfill: collected from historical articles to build the baseline, not from the live daily run.
Raw 47.9 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 47.9
Healthtech → AI staffing for healthcare relates to health SaaS
24/30
Stage fitSeries A, in mandate20/20
Cheque fit$13M, within $500K–$20M10/10
Tracked investorTogether Fund (existing), tracked4/12
Geography fitCity not reported0/5
RecencyAnnounced 5 days ago1.4/5
Ecosystem significance93th pct cheque for Series A × Healthtech (n=7); investor tier 96th pct (Blume Ventures); 4 sources17.1/18
Raw 76.5 × confidence 1Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 76.5
Sector fitHealthtech → dental care relates closely to care delivery24/30
Raw 54.5 × confidence 1Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 54.5
0/20
Cheque fitAmount undisclosed (neutral, not penalised)4/10
Raw 26.4 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 26.4
Stage fitSeries A, in mandate20/20
Cheque fit$7.0M, within $500K–$20M10/10
Tracked investor3one4 Capital (lead), tracked12/12
Geography fitDehradun, other city1/5
RecencyBefore the current digest window0/5
Ecosystem significance64th pct cheque for Series A × Healthtech (n=7); investor tier 100th pct (3one4 Capital); 1 source12.1/18
Override · Supplier to Even Healthcare (tracked company)+15
Raw 85.1 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 85.1
Override · Competes with Even Healthcare (tracked company)+35
Raw 70 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 70
Raw 56.4 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 56.4
Healthtech → Diagnostics is listed core sub-sector
Override · Supplier to Even Healthcare (tracked company)+15
Raw 65.1 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 65.1
Sector fitHealthtech → In-Clinic Healthcare matches care delivery
30/30
Stage fitPre-Series A, in mandate20/20
Cheque fit$936K, within $500K–$20M10/10
Tracked investorNo tracked investor0/12
Geography fitCity not reported0/5
RecencyBefore the current digest window0/5
Ecosystem significance15th pct cheque for Pre-Series A (all sectors) (n=24); investor tier 39th pct (Chetan Jain); 2 sources5.2/18
Override · Competes with Even Healthcare (tracked company)+35
Raw 100.2 × confidence 1Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 100
Sector fitHealthtech → Pharmaceutical closely relates to pharma supply
Raw 55.4 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 55.4
24/30
Stage fitSeries A, in mandate20/20
Cheque fit$4.6M, within $500K–$20M10/10
Tracked investorElevation Capital (existing), tracked4/12
Geography fitCity not reported0/5
RecencyBefore the current digest window0/5
Ecosystem significance21th pct cheque for Series A × Healthtech (n=7); investor tier 99th pct (Elevation Capital); 1 source8.2/18
Raw 56.3 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 56.3
Healthtech → Telemedicine matches care delivery
30/30
Stage fitSeed, in mandate20/20
Cheque fitAmount undisclosed (neutral, not penalised)4/10
Override · Supplier to Even Healthcare (tracked company)+15
Raw 72.9 × confidence 1Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 72.9
30/30
Stage fitRound not named in the article0/20
Cheque fitAmount undisclosed (neutral, not penalised)4/10
Tracked investorNo tracked investor0/12
Geography fitCity not reported0/5
RecencyBefore the current digest window0/5
Ecosystem significancecheque size unknown; no ranked investor; 1 source0.9/18
Raw 29.7 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 29.7
Sector fitHealthtech → In-Clinic Healthcare matches care delivery
Override · Competes with Even Healthcare (tracked company)+35
Raw 105.5 × confidence 1Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 100
18/30
Stage fitSeries A, in mandate20/20
Cheque fit$2.5M, within $500K–$20M10/10
Tracked investorNo tracked investor0/12
Geography fitCity not reported0/5
RecencyBefore the current digest window0/5
Ecosystem significance7th pct cheque for Series A × Healthtech (n=7); investor tier 92th pct (Equentis Angel Fund); 1 source6.5/18
Raw 46.3 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 46.3
Sector fitHealthtech → Fitness & Wellness is unlisted sub-sector18/30
Raw 78.5 × confidence 1Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 78.5
18/30
Stage fitPre-Series A, in mandate20/20
Cheque fit$2.0M, within $500K–$20M10/10
Tracked investorNo tracked investor0/12
Geography fitCity not reported0/5
RecencyBefore the current digest window0/5
Ecosystem significance40th pct cheque for Pre-Series A (all sectors) (n=24); investor tier 92th pct (Equentis Angel Fund); 1 source9.5/18
Raw 48.9 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 48.9
18/30
Stage fitRound not named in the article0/20
Cheque fitAmount undisclosed (neutral, not penalised)4/10
Raw 24 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 24
Sector fitHealthtech → Therapy (mental health primary match)30/30
Stage fitPre-Series A, in mandate20/20
Cheque fit$6.7M, within $500K–$20M10/10
Tracked investorNo tracked investor0/12
Geography fitMumbai, primary geography5/5
RecencyBefore the current digest window0/5
Ecosystem significance85th pct cheque for Pre-Series A (all sectors) (n=24); investor tier 92th pct (Inflexor Ventures); 2 sources14.5/18
Raw 79.5 × confidence 1Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 79.5
Sector fitHealthtech → Therapy (mental health primary match)30/30
Stage fitSeries A, in mandate20/20
Cheque fit$5.0M, within $500K–$20M10/10
Tracked investorNo tracked investor0/12
Geography fitCity not reported0/5
RecencyBefore the current digest window0/5
Ecosystem significance36th pct cheque for Series A × Healthtech (n=7); investor tier 98th pct (Rainmatter); 2 sources10.3/18
Raw 70.3 × confidence 1Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 70.3
Healthtech → Healthcare Devices (closely related to diagnostics)
24/30
Stage fitPre-Series A, in mandate20/20
Cheque fit$1.6M, within $500K–$20M10/10
Tracked investorNo tracked investor0/12
Geography fitBengaluru, primary geography5/5
RecencyBefore the current digest window0/5
Ecosystem significance35th pct cheque for Pre-Series A (all sectors) (n=24); investor tier 92th pct (Inflexor Ventures); 2 sources10/18
Raw 69 × confidence 1Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 69
18/30
Stage fitRound not named in the article0/20
Cheque fitAmount undisclosed (neutral, not penalised)4/10
Raw 21.3 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 21.3
18/30
Stage fitSeries A, in mandate20/20
Cheque fit$10M, within $500K–$20M10/10
Tracked investorNo tracked investor0/12
Geography fitCity not reported0/5
RecencyBefore the current digest window0/5
Ecosystem significance79th pct cheque for Series A × Healthtech (n=7); investor tier 85th pct (International Finance Corporation); 1 source12.5/18
Raw 51.4 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 51.4
18/30
Stage fitSeed, in mandate20/20
Cheque fit$1.0M, within $500K–$20M10/10
Tracked investorNo tracked investor0/12
Geography fitCity not reported0/5
RecencyBefore the current digest window0/5
Ecosystem significance27th pct cheque for Seed (all sectors) (n=58); investor tier 39th pct (Unicorn India Ventures); 1 source5.4/18
Raw 45.4 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 45.4
Sector fitHealthtech → Lifescience (unmentioned sub-sector in core)18/30
Raw 52.7 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 52.7
18/30
Stage fitSeries A, in mandate20/20
Cheque fit$6.0M, within $500K–$20M10/10
Tracked investorNo tracked investor0/12
Geography fitCity not reported0/5
RecencyBefore the current digest window0/5
Ecosystem significance50th pct cheque for Series A × Healthtech (n=7); investor tier 85th pct (Momentum Capital); 1 source10/18
Raw 49.3 × confidence 0.85Points from the rows above, multiplied by how sure we are of the facts (fewer sources or disputed fields lower it), then capped at 100.Score 49.3